Peptide glossary: the terms on a certificate, A to Z.

Sixty terms you meet on research-peptide certificates, product pages and this site's guides, each in one or two plain sentences with a link to the deeper article where one exists.

Basics11 min read

Key takeaway

Most confusion on a certificate comes from four pairs of terms. Purity (HPLC area-%) is not identity (a mass match by LC-MS). Net peptide content is not purity: it is the peptide share of the powder once counter-ions and water are counted. A lot is the unit a certificate speaks for. And an endotoxin Pass is a verdict, while the EU/mL figure printed beside it on a Vitrapep certificate is the assay’s sensitivity.

At a glance

Article typeBasics
TopicPeptide science
Studies cited14
Related productsResearch peptide catalog

This peptide glossary defines the terms you meet on research-peptide certificates, product pages and the articles on this site. Each entry is one or two plain sentences, with a link to the deeper guide where one exists. It covers testing, chemistry, handling and US regulation. It does not cover what individual compounds do.

Quick answer: The terms that matter most on a peptide certificate are identity (is it the right molecule, usually by LC-MS), purity (how much of the sample is the main peak, by HPLC), net content (how much is in the vial), endotoxin (a test for bacterial lipopolysaccharide, by LAL) and the lot number (which batch the results describe). Jump to any term below by its letter group, or link straight to an entry by its anchor.

Common abbreviations at a glance

Table 1

Abbreviations on peptide certificates and pages

Abbreviation Stands for Entry
COACertificate of analysisCertificate of analysis
HPLCHigh-performance liquid chromatographyHPLC
LC-MSLiquid chromatography–mass spectrometryLC-MS
m/zMass-to-charge ratiom/z
LALLimulus amebocyte lysateLAL
EUEndotoxin unitEndotoxin unit
rFCRecombinant Factor CRecombinant Factor C
TFATrifluoroacetic acid, or its salt, trifluoroacetateTFA
SPPSSolid-phase peptide synthesisSPPS
RUOResearch use onlyResearch use only
USPUnited States PharmacopeiaUSP
ICHInternational Council for HarmonisationSpecification
NDANew Drug ApplicationNDA
WADAWorld Anti-Doping AgencyWADA

A to C

503A
Section 503A of the Federal Food, Drug, and Cosmetic Act sets the conditions under which compounded human drugs are exempt from parts of the Act. One condition, the FDA says, is a valid patient-specific prescription. See the 2023 FDA 503A peptide list.
503B
Section 503B created outsourcing facilities, a voluntary category of compounders that, unlike 503A compounders, are subject to CGMP requirements. Vitrapep is neither a 503A compounder nor a 503B outsourcing facility.
Acceptance criteria
The numerical limits, ranges or other measures a test result must meet, in the words of ICH Q6A. On a certificate they appear as the limit beside each result. See specification.
Acetate salt
A peptide whose counter-ion is acetate. TFA left from synthesis can be exchanged for the ion of a weaker acid such as acetic acid, and Roux and colleagues compared ways of doing that exchange.
Amino acid
The NHGRI glossary calls it the building block of proteins and counts 20 different amino acids. Peptides are short chains of them. See what are peptides.
Appearance
A test that records what the material looks like. ICH Q6A calls it the description: a qualitative statement of the substance’s state and color.
Area-% (area percent)
The main peak’s share of all detected peak area on an HPLC chromatogram, the usual basis for a peptide purity figure. A USP and MHRA review reports chromatographic impurities on this basis. See HPLC purity, explained.
Bacteriostatic water
The USP monograph describes it as sterilized Water for Injection containing one or more suitable antimicrobial agents. See bacteriostatic water, explained.
Certificate of analysis (COA)
A lab report for one lot that lists each test, its acceptance limits and the results. ICH Q7 adds that it should be dated and signed. See how to read a COA and COA vs MSDS.
Charge state
The number of charges an ion carries. Electrospray often gives a peptide several, so one molecule shows up as a series of m/z peaks, and software combines them into one mass in a step Agilent’s LC/MS primer calls deconvolution. See LC-MS and peptide identity.
Chromatogram
The trace a chromatography detector draws as separated components leave the column: signal against time, with one peak per component. USP chapter <621> covers chromatography.
Counter-ion
An ion that balances a peptide’s charge in the solid. Bachem notes that a sample’s gross weight includes the peptide, its counter-ions, such as acetate or trifluoroacetate, and adhered water.

D to H

D-amino acid
The mirror-image form of an amino acid. ICH Q6A defines enantiomers as having the same formula but nonsuperimposable mirror-image arrangements, so a D-for-L swap leaves the mass unchanged and, as Verlander and Rode note, mass spectrometry alone cannot detect it.
Deamidation
Loss of the amide group from an asparagine (Asn) or glutamine (Gln) side chain, a reaction measured in peptides and proteins. It is one of the chemical routes by which peptides degrade. See how to store peptides.
Deletion sequence
An impurity missing one or more amino acids of the intended sequence. A review of peptide impurities links deletion and insertion impurities to inefficient Fmoc-deprotection and excess amino acid reagents during synthesis.
Endotoxin
The lipid A portion of lipopolysaccharide from Gram-negative bacteria, as Raetz and Whitfield describe it. It can trigger responses in cell experiments. See endotoxin testing, explained.
Endotoxin unit (EU)
A unit of endotoxin activity measured against a reference standard rather than by weight, because potency per nanogram varies between bacteria (Associates of Cape Cod). EU/mL is activity per milliliter of the solution tested.
Excipient
Any added ingredient other than the active compound. US drug rules call this an inactive ingredient: any component other than an active ingredient (21 CFR 210.3).
Expiration date
The date before which a batch is expected to stay within its shelf-life specification if stored under defined conditions, per ICH Q1A(R2). Compare re-test date.
Gel-clot
An LAL endotoxin method that reads whether a gel forms. Charles River describes it as a simple qualitative method.
Gross weight
The total weight of a peptide sample: the peptide, its counter-ions and adhered water, per Bachem. Compare net peptide content.
Heavy metals
Toxic elements tested as impurities. ICH Q3D(R2) puts arsenic, cadmium, mercury and lead in Class 1, the four elements Vitrapep’s production lab tests for.
HPLC
High-performance liquid chromatography: a column separates a sample into its components, and a detector, usually UV for peptides, records each as a peak. It is the usual basis for a purity figure. See HPLC purity, explained.
Hygroscopic
Prone to take up water from the air. Bachem says peptides tend to be hygroscopic, and that absorbed moisture reduces peptide content and may decrease stability.

I to L

Identity
Confirmation that a sample is the compound on the label. ICH Q6A says identification tests should be specific and that a single chromatographic retention time is not. See LC-MS and peptide identity.
Impurity
Any component that is not the defined chemical entity, in ICH Q6A’s definition. For peptides this includes deletion sequences, diastereomers and oxidized forms.
In vitro
In a test tube, plate or other lab vessel rather than in a living organism. Vitrapep supplies peptides for laboratory and in-vitro research.
LAL
Limulus amebocyte lysate: an extract of horseshoe crab blood cells that clots in the presence of endotoxin. It is the basis of the bacterial endotoxins test in USP <85>, run as gel-clot, turbidimetric or chromogenic assays.
LC-MS
Liquid chromatography–mass spectrometry: a chromatograph separates the sample and a mass spectrometer measures each component’s m/z. LC-MS/MS adds a fragmentation stage that Thermo Fisher says is commonly used to sequence proteins. See LC-MS and peptide identity.
Lot (batch)
A batch, or an identified part of one, with uniform character and quality within specified limits (21 CFR 210.3). A certificate speaks only for the lot it names.
Lot number
The code from which a lot’s full manufacturing and distribution history can be traced (21 CFR 210.3). On a Vitrapep vial it is printed on the label and opens that lot’s certificate on the COA lookup.
Lyophilization
Freeze-drying. The FDA’s inspection guide describes three stages, freezing, primary drying (sublimation) and secondary drying (desorption), and notes that products are made in lyophilized form because of their instability in solution. See how to store peptides.

M to O

Mass spectrometry (MS)
An analytical technique based on measuring the mass-to-charge ratio of ions related to the analyte, as USP chapter <736> defines it.
m/z
Mass-to-charge ratio, the quantity a mass spectrometer sorts ions by. Agilent’s LC/MS primer gives the arithmetic: a 100,000 u molecule with 10 charges appears at m/z 1,000.
Moisture (residual moisture)
The small amount of bound water left in a freeze-dried product, as Labconco’s freeze-drying guide defines it. The production lab reports it for each Vitrapep lot.
Molecular weight
The mass of a molecule, calculated from its formula. Agilent’s primer calls molecular weight determination a fundamental use of LC-MS and key to determining identity.
Monoisotopic mass
A mass calculated from a single isotope of each element; the IUPAC definition is based on the most abundant isotopes, as Attygalle and colleagues describe. Mass spectrometry is often used to determine a peptide’s monoisotopic mass.
NDA
New Drug Application: in the FDA’s words, the vehicle through which drug sponsors formally propose that the FDA approve a new pharmaceutical.
Net content
On a Vitrapep certificate, the amount of material measured in the vial, in milligrams, set against the label amount. Each lot’s figure is on its certificate.
Net peptide content
The fraction of peptidic material in a sample relative to counter-ions and residual water, per Bachem. It is not the same as purity, because it includes peptidic impurities.
Orthogonal methods
Tests based on different principles that check the same property, such as HPLC and mass spectrometry. The USP and MHRA review notes that multiple orthogonal techniques are typically used to verify a peptide’s structure.
Oxidation
A degradation reaction. Li, Schöneich and Borchardt name methionine, cysteine, histidine, tryptophan and tyrosine as the residues most susceptible.

P to R

Peptide
A short chain of amino acids, typically 2 to 50, linked by peptide bonds, per the NHGRI glossary. See what are peptides and peptide vs protein.
pH
A measure of how acidic or basic a solution is. Vitrapep’s production lab reports the pH of a test solution of each lot.
Prescription drug
Under 21 U.S.C. § 353(b)(1), a drug that may be dispensed only on a licensed practitioner’s prescription, because of its potential for harm or because its approved application limits its use.
Purity
For a peptide, usually the HPLC area-% of the main peak. It shows how much of the sample is one component, not which component. See HPLC purity, explained.
Racemization
Conversion of an amino acid toward its mirror-image form. The D’Hondt review notes it can occur during Fmoc-deprotection and gives diastereomeric impurities with the same mass as the target.
Recombinant Factor C (rFC)
An endotoxin test reagent built from the horseshoe crab’s gene sequences, so it is nonanimal-derived. USP chapter <86> covers it as an alternative to the LAL test.
Re-test date
The date after which a substance should be examined again to confirm it still meets its specification, per ICH Q1A(R2).
Research use only (RUO)
A label that limits a product to laboratory research. Every Vitrapep product is for laboratory research use only and is not for human or veterinary use. See what research use only means.
Residual solvents
Organic volatile chemicals used or produced in manufacture that practical techniques do not completely remove, as ICH Q3C(R8) defines them.
Retention time
The time a component takes to pass through a chromatography column to the detector. Matching it to a reference standard is one identity check, but ICH Q6A says retention time alone is not specific.

S to Z

Sequence
The order of amino acids in a peptide chain. It fixes the chemical formula, and so the theoretical mass a lab compares against in an identity test.
Solubility
Whether, and how readily, a material dissolves in a stated solvent. Vitrapep’s production lab reports it for each lot.
Specification
A list of tests, references to analytical procedures and acceptance criteria that a substance should conform to, as ICH Q6A defines it. ICH is the International Council for Harmonisation.
SPPS
Solid-phase peptide synthesis, building a peptide chain while it is anchored to a solid support, first reported by R. B. Merrifield in 1963. See how peptides are made.
TFA
Trifluoroacetic acid, a reversed-phase HPLC solvent, and trifluoroacetate, its salt. Cornish and colleagues note that HPLC-purified peptides are often TFA salts, and found TFA reduced cell numbers in bone-cell cultures at 10−8 to 10−7 M.
Third-party testing
Testing of a lot by a lab separate from the seller, which issues its own certificate. See the peptide testing hub.
USP
The United States Pharmacopeia, which publishes the USP–NF of public standards, including test chapters such as <85> (bacterial endotoxins), <621> (chromatography) and <736> (mass spectrometry).
WADA
The World Anti-Doping Agency. Its 2026 Prohibited List came into force on 1 January 2026 and is a mandatory standard for all signatories of the World Anti-Doping Code. See peptides on the 2026 WADA list.

How Vitrapep tests each lot

11 tests per lot Two certificates Lookup by lot

Identity, purity, net content and endotoxin at Freedom Diagnostics, plus a production-lab panel, before any lot goes on sale. For laboratory research use only, not for human or veterinary use.

See how we test

Where these terms appear on Vitrapep

Each Vitrapep lot has two certificates. Freedom Diagnostics, an independent lab, reports identity by LC-MS, purity by HPLC-UV, net content, and endotoxin by LAL under USP <85>. The production lab adds appearance, solubility, pH, moisture, impurities, residual solvents and heavy metals. The Freedom Diagnostics certificate is published, and each one carries its lot number and test date. Open it on the certificate lookup page. The quality page explains the process, and every product in the catalog is for laboratory research use only, not for human or veterinary use.

Frequently asked questions

What is the difference between purity and net peptide content?

Purity is the main peak’s share of HPLC peak area. Net peptide content is the peptide share of the powder once counter-ions and water are counted, and it includes peptidic impurities.

What is the difference between a lot and a batch?

Under 21 CFR 210.3 a lot is a batch, or an identified part of one, with uniform character and quality. In practice a certificate names one lot.

Why does TFA appear on peptide documents?

Because TFA is used in synthesis and HPLC purification, and HPLC-purified peptides are often TFA salts. Some are exchanged to acetate salts.

What does 0.05 EU/mL mean on a Vitrapep certificate?

It is the endotoxin assay’s detection sensitivity. The result is the Pass beside it. The figure is not a measured value or a limit and should not be converted to EU/mg.

What to know now

  • Identity vs purity: a mass match says what; HPLC area-% says how much.
  • Net peptide content: the peptide share of the powder, not purity.
  • Lot: the unit a certificate speaks for; match it to the vial.
  • Endotoxin: bacterial lipopolysaccharide, measured in EU against a standard.
  • Counter-ions: TFA or acetate, part of the powder’s gross weight.
  • Regulatory terms: 503A, 503B, NDA and prescription drug describe medicines, not research reagents.

What we’re watching

Definitions follow the guidance behind them. On July 28, 2026, the FDA withdrew its 2021 guidance on generic synthetic peptides and published 17 revised draft product-specific guidances covering impurity thresholds and related tests. We will update entries such as impurity and specification if the final versions change how those terms are used.

Also in the library

Sources: National Human Genome Research Institute. Amino Acids . Talking Glossary of Genomic and Genetic Terms. https://www.genome.gov/genetics-glossary/Amino-Acids, Amino Acids; National Human Genome Research Institute. Peptide . Talking Glossary of Genomic and Genetic Terms. https://www.genome.gov/genetics-glossary/Peptide, Peptide; U.S. Food and Drug Administration. Human Drug Compounding Laws (content current as of 12/17/2024). https://www.fda.gov/drugs/human-drug-compounding/human-drug-compounding-laws, Human Drug Compounding Laws; U.S. Food and Drug Administration. New Drug Application (NDA) (content current as of 01/21/2022). https://www.fda.gov/drugs/types-applications/new-drug-application-nda, New Drug Application (NDA); 21 U.S.C. &sect; 353. Exemptions and consideration for certain drugs; 21 C.F.R. &sect; 210.3. Definitions. Legal Information Institute; International Council for Harmonisation 1999; International Council for Harmonisation 2000, ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients; International Council for Harmonisation 2003, ICH Q1A(R2): Stability Testing of New Drug Substances and Products; International Council for Harmonisation 2021, ICH Q3C(R8): Impurities: Guideline for Residual Solvents; International Council for Harmonisation 2022, ICH Q3D(R2): Guideline for Elemental Impurities; United States Pharmacopeia. <621> Chromatography (general chapter). USP–NF. https://doi.org/10.31003/USPNF_M99380_01_01; United States Pharmacopeia. <736> Mass Spectrometry (general chapter). USP–NF. https://doi.org/10.31003/USPNF_M99525_02_01; United States Pharmacopeia. <85> Bacterial Endotoxins Test (general chapter). USP–NF. https://doi.org/10.31003/USPNF_M98830_02_01; United States Pharmacopeia. <86> Bacterial Endotoxins Test Using Recombinant Reagents (general chapter). USP–NF. https://doi.org/10.31003/USPNF_M16015_02_01; United States Pharmacopeia. Bacteriostatic Water for Injection (monograph). USP–NF. https://doi.org/10.31003/USPNF_M88830_03_01, Bacteriostatic Water for Injection; Bachem. FAQ: frequently asked questions (net peptide content, FAQ: frequently asked questions; Bachem. Handling and Storage Guidelines for Peptides . Bachem Knowledge Center. https://www.bachem.com/knowledge-center/handling-and-storage-guidelines-for-peptides/, Handling and Storage Guidelines for Peptides; Roux 2008, Journal of Peptide Science; Cornish 1999, American Journal of Physiology; Merrifield 1963, Journal of the American Chemical Society; D’Hondt 2014, Journal of Pharmaceutical and Biomedical Analysis; McCarthy 2023, Pharmaceutical Research; Verlander 2014, BioPharm International; Attygalle 2022, Journal of the American Society for Mass Spectrometry; Agilent Technologies 2001, Basics of LC/MS: Primer; Thermo Fisher Scientific. Overview of Mass Spectrometry for Protein Analysis . https://www.thermofisher.com/us/en/home/life-science/protein-biology/protein-biology-learning-center/protein-biology-resource-library/pierce-protein-methods/overview-mass-spectrometry.html, Overview of Mass Spectrometry for Protein Analysis; Raetz 2002, Annual Review of Biochemistry; Dawson 1993, LAL Update; Charles River Laboratories 2019, Bacterial Endotoxin Testing Solutions; U.S. Food and Drug Administration. Lyophilization of Parenteral (7/93) . Inspection guide. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-guides/lyophilization-parenteral-793, Lyophilization of Parenteral (7/93); Labconco Corporation. A Guide to Freeze Drying for the Laboratory (industry service publication). Copy distributed by Thermo Fisher Scientific. https://documents.thermofisher.com/TFS-Assets/ANZ/brochures/labconco-guide-fd.pdf, A Guide to Freeze Drying for the Laboratory; Robinson 2001, Proceedings of the National Academy of Sciences; Li 1995, Biotechnology and Bioengineering; International Paralympic Committee 2025, WADA’s 2026 Prohibited List comes into force on 1 January; U.S. Food and Drug Administration 2026. All 36 citations

Back to the research library

References

  1. National Human Genome Research Institute. Amino Acids. Talking Glossary of Genomic and Genetic Terms. https://www.genome.gov/genetics-glossary/Amino-Acids
  2. National Human Genome Research Institute. Peptide. Talking Glossary of Genomic and Genetic Terms. https://www.genome.gov/genetics-glossary/Peptide
  3. U.S. Food and Drug Administration. Human Drug Compounding Laws (content current as of 12/17/2024). https://www.fda.gov/drugs/human-drug-compounding/human-drug-compounding-laws
  4. U.S. Food and Drug Administration. New Drug Application (NDA) (content current as of 01/21/2022). https://www.fda.gov/drugs/types-applications/new-drug-application-nda
  5. 21 U.S.C. § 353. Exemptions and consideration for certain drugs, devices, and biological products. Legal Information Institute, Cornell Law School. https://www.law.cornell.edu/uscode/text/21/353
  6. 21 C.F.R. § 210.3. Definitions. Legal Information Institute, Cornell Law School. https://www.law.cornell.edu/cfr/text/21/210.3
  7. International Council for Harmonisation. (1999). ICH Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. https://database.ich.org/sites/default/files/Q6A%20Guideline.pdf
  8. International Council for Harmonisation. (2000). ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. https://database.ich.org/sites/default/files/Q7%20Guideline.pdf
  9. International Council for Harmonisation. (2003). ICH Q1A(R2): Stability Testing of New Drug Substances and Products. https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf
  10. International Council for Harmonisation. (2021). ICH Q3C(R8): Impurities: Guideline for Residual Solvents. https://database.ich.org/sites/default/files/ICH_Q3C-R8_Guideline_Step4_2021_0422.pdf
  11. International Council for Harmonisation. (2022). ICH Q3D(R2): Guideline for Elemental Impurities. https://database.ich.org/sites/default/files/Q3D-R2_Guideline_Step4_2022_0308.pdf
  12. United States Pharmacopeia. <621> Chromatography (general chapter). USP–NF. https://doi.org/10.31003/USPNF_M99380_01_01
  13. United States Pharmacopeia. <736> Mass Spectrometry (general chapter). USP–NF. https://doi.org/10.31003/USPNF_M99525_02_01
  14. United States Pharmacopeia. <85> Bacterial Endotoxins Test (general chapter). USP–NF. https://doi.org/10.31003/USPNF_M98830_02_01
  15. United States Pharmacopeia. <86> Bacterial Endotoxins Test Using Recombinant Reagents (general chapter). USP–NF. https://doi.org/10.31003/USPNF_M16015_02_01
  16. United States Pharmacopeia. Bacteriostatic Water for Injection (monograph). USP–NF. https://doi.org/10.31003/USPNF_M88830_03_01
  17. Bachem. FAQ: frequently asked questions (net peptide content, gross weight, counter-ions). https://www.bachem.com/helpie_faq/what-does-net-peptide-content-mean/
  18. Bachem. Handling and Storage Guidelines for Peptides. Bachem Knowledge Center. https://www.bachem.com/knowledge-center/handling-and-storage-guidelines-for-peptides/
  19. Roux, S., Zékri, E., Rousseau, B., Paternostre, M., Cintrat, J.-C., & Fay, N. (2008). Elimination and exchange of trifluoroacetate counter-ion from cationic peptides: A critical evaluation of different approaches. Journal of Peptide Science, 14(3), 354–359. https://doi.org/10.1002/psc.951
  20. Cornish, J., Callon, K. E., Lin, C. Q., Xiao, C. L., Mulvey, T. B., Cooper, G. J., & Reid, I. R. (1999). Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. American Journal of Physiology, 277(5), E779–E783. https://doi.org/10.1152/ajpendo.1999.277.5.E779
  21. Merrifield, R. B. (1963). Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. Journal of the American Chemical Society, 85(14), 2149–2154. https://doi.org/10.1021/ja00897a025
  22. D’Hondt, M., Bracke, N., Taevernier, L., Gevaert, B., Verbeke, F., Wynendaele, E., & De Spiegeleer, B. (2014). Related impurities in peptide medicines. Journal of Pharmaceutical and Biomedical Analysis, 101, 2–30. https://doi.org/10.1016/j.jpba.2014.06.012
  23. McCarthy, D., Han, Y., Carrick, K., Schmidt, D., Workman, W., Matejtschuk, P., Duru, C., & Atouf, F. (2023). Reference standards to support quality of synthetic peptide therapeutics. Pharmaceutical Research, 40(6), 1317–1328. https://doi.org/10.1007/s11095-023-03493-1
  24. Verlander, M., & Rode, H. (2014, March 1). Control strategies for synthetic therapeutic peptide APIs, Part I: Analytical consideration. BioPharm International. https://www.biopharminternational.com/view/control-strategies-synthetic-therapeutic-peptide-apis-part-i-analytical-consideration
  25. Attygalle, A. B., Pavlov, J., & Ruzicka, J. (2022). Monoisotopic mass? Journal of the American Society for Mass Spectrometry, 33(1), 5–10. https://doi.org/10.1021/jasms.1c00110
  26. Agilent Technologies. (2001). Basics of LC/MS: Primer (publication 5988-2045EN). Copy hosted by the Boston University Chemical Instrumentation Center. https://sites.bu.edu/cheminst/files/2021/06/LCMSPrimer.pdf
  27. Thermo Fisher Scientific. Overview of Mass Spectrometry for Protein Analysis. https://www.thermofisher.com/us/en/home/life-science/protein-biology/protein-biology-learning-center/protein-biology-resource-library/pierce-protein-methods/overview-mass-spectrometry.html
  28. Raetz, C. R. H., & Whitfield, C. (2002). Lipopolysaccharide endotoxins. Annual Review of Biochemistry, 71, 635–700. https://doi.org/10.1146/annurev.biochem.71.110601.135414
  29. Dawson, M. E. (1993). Endotoxin standards and CSE potency. LAL Update, 11(4). Associates of Cape Cod. https://www.acciusa.com/pdfs/newsletter/lal_vol.11_no.4.pdf
  30. Charles River Laboratories. (2019). Bacterial Endotoxin Testing Solutions (product and service sheet). https://www.criver.com/sites/default/files/resources/BacterialEndotoxinTestingProductServiceSheet.pdf
  31. U.S. Food and Drug Administration. Lyophilization of Parenteral (7/93). Inspection guide. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-guides/lyophilization-parenteral-793
  32. Labconco Corporation. A Guide to Freeze Drying for the Laboratory (industry service publication). Copy distributed by Thermo Fisher Scientific. https://documents.thermofisher.com/TFS-Assets/ANZ/brochures/labconco-guide-fd.pdf
  33. Robinson, N. E., & Robinson, A. B. (2001). Molecular clocks. Proceedings of the National Academy of Sciences, 98(3), 944–949. https://doi.org/10.1073/pnas.98.3.944
  34. Li, S., Schöneich, C., & Borchardt, R. T. (1995). Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization. Biotechnology and Bioengineering, 48(5), 490–500. https://doi.org/10.1002/bit.260480511
  35. International Paralympic Committee. (2025, December 30). WADA’s 2026 Prohibited List comes into force on 1 January. https://www.paralympic.org/news/wada-2026-prohibited-list-january
  36. U.S. Food and Drug Administration. (2026, July 28). FDA Publishes Revised Draft Product-Specific Guidances for Certain Generic Peptide Products. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-publishes-revised-draft-product-specific-guidances-certain-generic-peptide-products